Automated Reporting Platform for Limited Distribution Drug Data Access
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current workflow for managing limited distribution drugs (LDDs) is inefficient, leading to administrative overheads, duplication of efforts, and delays in patient access due to different data entry requirements for each pharmaceutical manufacturer, lack of communication protocols, and manual processes prone to errors, which hinders accurate tracking and distribution of LDDs.
Innovation Solution
A computer-implemented method that includes a middle layer to interface specialty pharmacies with pharmaceutical manufacturers, generating standardized report data entries devoid of patient or provider identifiers, and automating the reporting process to reduce duplication and improve data access, facilitating faster patient access to LDDs and patient-assistance programs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If manual data entry processes are used for each pharmaceutical manufacturer, then data can be collected from specialty pharmacies, but administrative overhead increases and duplication of efforts occurs
Solution Approach 1:
The patent merges multiple data entry operations into a single automated process. The system consolidates data collection from multiple specialty pharmacies into one centralized platform that automatically generates and transmits reports to multiple pharmaceutical manufacturers, eliminating the need for separate manual data entry for each manufacturer.
Solution Approach 2:
The patent introduces an intermediary reporting system that acts as a mediator between specialty pharmacies and pharmaceutical manufacturers. This intermediate platform automatically receives prescription data from pharmacies, processes it according to manufacturer-specific formats, and transmits reports, thereby eliminating direct manual interaction between pharmacies and multiple manufacturers.
2Manufacturing precision
If separate data entry is performed for each pharmaceutical manufacturer, then manufacturer-specific data requirements can be met, but duplication of efforts and errors increase
Solution Approach 1:
The patent creates a universal reporting platform that can handle multiple pharmaceutical manufacturers' data requirements through a single system. The intermediary system is designed to accommodate different manufacturer-specific data formats and requirements while maintaining a unified data collection process, thereby reducing errors from manual re-entry.
Solution Approach 2:
The patent uses automated copying and transformation of data from a single source (specialty pharmacy prescription data) into multiple manufacturer-specific report formats. The system automatically replicates and adapts the core prescription data to meet different manufacturer requirements without manual intervention, ensuring consistency and accuracy.
3Speed
If manual reporting processes are used, then data can be transmitted to pharmaceutical manufacturers, but latency in patient access increases from weeks to days
Solution Approach 1:
The patent replaces manual mechanical data entry and transmission processes with an automated electronic reporting system. The intermediary platform automatically receives prescription data from specialty pharmacies via electronic interfaces, processes it, and transmits reports to pharmaceutical manufacturers through automated electronic communication, eliminating the delays associated with manual handling.
Solution Approach 2:
The patent implements preliminary automated processing of prescription data as it is received from specialty pharmacies. The system immediately begins processing and formatting data according to manufacturer requirements, preparing reports in advance for rapid transmission, thereby minimizing the latency between prescription initiation and manufacturer notification.
4Adaptability or versatility
If different data entry requirements are imposed by each manufacturer, then manufacturer-specific needs are met, but lack of communication protocols increases administrative burden
Solution Approach 1:
The patent designs a universal intermediary reporting system that can adapt to different manufacturer-specific data requirements through a single interface. The system maintains a standardized data collection process while automatically transforming the data to meet various manufacturer formats and requirements, thereby preserving ease of operation for pharmacies while accommodating manufacturer diversity.
Data Source
AI summary
A computer-assisted method that includes: receiving a first list of data entries set forth by a first pharmaceutical manufacturer for a first limited distribution drug for a target condition; receiving first prescription data from a server at a first specialty pharmacy authorized to distribute the first limited distribution drug, the first prescription data initiated by a patient, at the first specialty pharmacy, for whom a healthcare provider of the patient had prescribed the limited distribution drug; automatically generating first report data entries based on the first prescription data and according to the first list set forth by the first pharmaceutical manufacturer, the first report data entries devoid of information identifying the patient or the prescribing healthcare provider; transmitting the generated first report data entries to the first pharmaceutical manufacturer; and receiving a response from the first pharmaceutical manufacturer.